CD44 and cancer: A multivariate analysis indicated that the percentage of CD44+/CD24− cancer cells was an independent prognostic factor related to metastasis (p = 0.003), suggesting a significant clinical relevance of the CD44+/CD24− subclass of breast cancer cells.